Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Zinc Supplementation and Transdermal Clobetasol in the Prophylaxis of Regorafenib-Induced Hand-Foot Skin Reaction: A Prospective Non-Randomized Study

NCT06856590 is registered in ClinicalTrials.gov with Gazi University as lead sponsor.

NCT NCT06856590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06856590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Zinc Supplementation and Transdermal Clobetasol in the Prophylaxis of Regorafenib-Induced Hand-Foot Skin Reaction: A Prospective Non-Randomized Study
Lead sponsor
Gazi University
Phase
Not applicable
Overall status
Completed
Start date
February 20, 2025
Completion date
September 7, 2025
Enrollment
150 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hand-foot skin reaction (hfsr)